|
1
|
Heigener DF and Reck M: Lung cancer in
2017: Giant steps and stumbling blocks. Nat Rev Clin Oncol.
15:71–72. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nagasaka M and Gadgeel SM: Role of
chemotherapy and targeted therapy in early-stage non-small cell
lung cancer. Expert Rev Anticancer Ther. 18:63–70. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mayekar MK and Bivona TG: Current
landscape of targeted therapy in lung cancer. Clin Pharmacol Ther.
102:757–764. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Saad N, Poudel A, Basnet A and Gajra A:
Epidermal growth factor receptor T790M mutation-positive metastatic
non-small-cell lung cancer: Focus on osimertinib (AZD9291). Onco
Targets Ther. 10:1757–1766. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jänne PA, Yang JC, Kim DW, Planchard D,
Ohe Y, Ramalingam SS, Ahn MJ, Kim SW, Su WC, Horn L, et al: AZD9291
in EGFR inhibitor-resistant non-small-cell lung cancer. N Engl J
Med. 372:1689–1699. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thress KS, Paweletz CP, Felip E, Cho BC,
Stetson D, Dougherty B, Lai Z, Markovets A, Vivancos A, Kuang Y, et
al: Acquired EGFR C797S mutation mediates resistance to AZD9291 in
non-small cell lung cancer harboring EGFR T790M. Nat Med.
21:560–562. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jimenez-Preitner M, Berney X, Uldry M,
Vitali A, Cinti S, Ledford JG and Thorens B: Plac8 is an inducer of
C/EBPβ required for brown fat differentiation, thermoregulation,
and control of body weight. Cell Metab. 14:658–670. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Q, Lu TF, Liu D, Hu PF, Sun B, Ma JZ,
Wang WJ, Wang KF, Zhang WX, Chen J, et al: Screening and analyzing
genes associated with Amur tiger placental development. Genet Mol
Res. 13:7869–7878. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kaistha BP, Lorenz H, Schmidt H, Sipos B,
Pawlak M, Gierke B, Kreider R, Lankat-Buttgereit B, Sauer M,
Fiedler L, et al: PLAC8 localizes to the inner plasma membrane of
pancreatic cancer cells and regulates cell growth and disease
progression through critical cell-cycle regulatory pathways. Cancer
Res. 76:96–107. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Uehara H, Takahashi T and Izumi K:
Induction of retinol-binding protein 4 and placenta-specific 8
expression in human prostate cancer cells remaining in bone
following osteolytic tumor growth inhibition by osteoprotegerin.
Int J Oncol. 43:365–374. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zou L, Chai J, Gao Y, Guan J, Liu Q and Du
JJ: Down-regulated PLAC8 promotes hepatocellular carcinoma cell
proliferation by enhancing PI3K/Akt/GSK3β/Wnt/β-catenin signaling.
Biomed Pharmacother. 84:139–146. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li C, Ma H, Wang Y, Cao Z, Graves-Deal R,
Powell AE, Starchenko A, Ayers GD, Washington MK, Kamath V, et al:
Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon
cancer. J Clin Invest. 124:2172–2187. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shi L, Xiao L, Heng B, Mo S, Chen W and Su
Z: Overexpression of placenta specific 8 is associated with
malignant progression and poor prognosis of clear cell renal cell
carcinoma. Int Urol Nephrol. 49:1165–1176. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu X, Chai S, Wang P, Zhang C, Yang Y,
Yang Y and Wang K: Aldehyde dehydrogenases and cancer stem cells.
Cancer Lett. 369:50–57. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Koppaka V, Thompson DC, Chen Y, Ellermann
M, Nicolaou KC, Juvonen RO, Petersen D, Deitrich RA, Hurley TD and
Vasiliou V: Aldehyde dehydrogenase inhibitors: a comprehensive
review of the pharmacology, mechanism of action, substrate
specificity, and clinical application. Pharmacol Rev. 64:520–539.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu J, Alharbi A, Shan H, Hao Y, Snetsinger
B, Rauh MJ and Yang X: TAZ induces lung cancer stem cell properties
and tumorigenesis by up-regulating ALDH1A1. Oncotarget.
8:38426–38443. 2017.PubMed/NCBI
|
|
17
|
Duong HQ, You KS, Oh S, Kwak SJ and Seong
YS: Silencing of NRF2 reduces the expression of ALDH1A1 and ALDH3A1
and sensitizes to 5-FU in pancreatic cancer cells. Antioxidants
(Basel). 6(pii): E522017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Alamgeer M, Ganju V, Szczepny A, Russell
PA, Prodanovic Z, Kumar B, Wainer Z, Brown T, Schneider-Kolsky M,
Conron M, et al: The prognostic significance of aldehyde
dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage
non-small cell lung cancer. Thorax. 68:1095–1104. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wei Y, Wu S, Xu W, Liang Y, Li Y, Zhao W
and Wu J: Depleted aldehyde dehydrogenase 1A1 (ALDH1A1) reverses
cisplatin resistance of human lung adenocarcinoma cell A549/DDP.
Thorac Cancer. 8:26–32. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lai YH, Lin SY, Wu YS, Chen HW and Chen
JJW: AC-93253 iodide, a novel Src inhibitor, suppresses NSCLC
progression by modulating multiple Src-related signaling pathways.
J Hematol Oncol. 10:1722017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tan CS, Gilligan D and Pacey S: Treatment
approaches for EGFR-inhibitor-resistant patients with
non-small-cell lung cancer. Lancet Oncol. 16:e447–e459. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu HA, Arcila ME, Rekhtman N, Sima CS,
Zakowski MF, Pao W, Kris MG, Miller VA, Ladanyi M and Riely GJ:
Analysis of tumor specimens at the time of acquired resistance to
EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers.
Clin Cancer Res. 19:2240–2247. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kolluru V, Pal D, Papu John AMS, Ankem MK,
Freedman JH and Damodaran C: Induction of Plac8 promotes
pro-survival function of autophagy in cadmium-induced prostate
carcinogenesis. Cancer Lett. 408:121–129. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kinsey C, Balakrishnan V, O'Dell MR, Huang
JL, Newman L, Whitney-Miller CL, Hezel AF and Land H: Plac8 links
oncogenic mutations to regulation of autophagy and is critical to
pancreatic cancer progression. Cell Rep. 7:1143–1155. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Leon G, MacDonagh L, Finn SP, Cuffe S and
Barr MP: Cancer stem cells in drug resistant lung cancer: Targeting
cell surface markers and signaling pathways. Pharmacol Ther.
158:71–90. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Prieto-Vila M, Takahashi RU, Usuba W,
Kohama I and Ochiya T: Drug resistance driven by cancer stem cells
and their niche. Int J Mol Sci. 18(pii): E25742017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
MacDonagh L, Gray SG, Breen E, Cuffe S,
Finn SP, O'Byrne KJ and Barr MP: Lung cancer stem cells: The root
of resistance. Cancer Lett. 372:147–156. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hashida S, Yamamoto H, Shien K, Miyoshi Y,
Ohtsuka T, Suzawa K, Watanabe M, Maki Y, Soh J, Asano H, et al:
Acquisition of cancer stem cell-like properties in non-small cell
lung cancer with acquired resistance to afatinib. Cancer Sci.
106:1377–1384. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jimenez-Preitner M, Berney X and Thorens
B: Plac8 is required for white adipocyte differentiation in vitro
and cell number control in vivo. PLoS One. 7:e487672012. View Article : Google Scholar : PubMed/NCBI
|
